Ramesh Rithvik, Quintana Daniel, Osorio Robert C, Jimenez Christian J, Aghi Manish K, McDermott Michael W, Theodosopoulos Philip V, Goldschmidt Ezequiel
Department of Neurological Surgery, University of California, San Francisco, San Francisco , California , USA.
Department of Neurosurgery, Miami Neuroscience Institute, Baptist Health South Florida, Miami , Florida , USA.
Neurosurgery. 2024 Dec 19;97(2):351-360. doi: 10.1227/neu.0000000000003309.
Intracranial epidermoid cysts are rare, slow-growing but highly recurrent tumors with incompletely understood symptoms, progression, complications, and outcomes. The aim of the study was to characterize the symptomatology, surgical management, and long-term outcomes of these tumors.
This single-center retrospective analysis identified patients with pathologically confirmed intracranial epidermoid cysts from 1989 to 2023. Demographic and clinical variables were collected at diagnosis, before and after each resection, and at the latest follow-up. Differences across time points were evaluated using analysis of variance with post hoc Tukey's honestly significant difference tests and Pearson χ 2 test with posthoc Bonferroni-corrected z-tests for independent proportions (significance: P ≤ .05). Kaplan-Meier, Cox regression, and multivariate logistic regression analyses were used to investigate predictors for recurrence-free survival and 30-day readmission following first surgery, respectively.
Of 146 patients in the final cohort, the average age at diagnosis was 40.3 years, and 52.1% of patients were female. The mean maximum tumor dimension at presentation was 4.3 cm. Most presenting symptoms were significantly reduced at the latest follow-up, including headaches (presentation: 40.4%/latest follow-up: 8.8%, P < .001), vertigo/nausea/vomiting (33.1%/3.7%, P < .001), ataxia/incoordination (22.8%/4.4%, P < .001), and seizures (11.8%/2.9%, P < .005). Similarly, significant improvements were observed in cranial nerve (CN) II deficits (11.0%/3.7%, P = .020) and CN V (11.8%/3.7%, P = .012) and CN VIII excitatory symptoms (11.8%/2.9%, P = .005). Following the first resection, 12.5% of patients were readmitted within 30 days; lumbar drain placement was associated with higher odds of readmission (adjusted odds ratio [95% CI] = 8.26 [1.29-88.19]). Evidence of tumor remnant on the immediate postoperative MRI was associated with a shorter time to recurrence following the first surgery ( P = .023).
The clinical progression of intracranial epidermoid cysts is marked by a spectrum of troublesome presenting symptoms and a notable tendency for recurrence, particularly following subtotal resection. Nevertheless, symptomatic improvement is the rule even if reoperations are needed, and mortality is exceedingly rare.
颅内表皮样囊肿是一种罕见的、生长缓慢但复发率高的肿瘤,其症状、进展、并发症及预后尚不完全清楚。本研究的目的是描述这些肿瘤的症状学、手术治疗及长期预后。
这项单中心回顾性分析确定了1989年至2023年期间经病理证实的颅内表皮样囊肿患者。在诊断时、每次切除术前和术后以及最近一次随访时收集人口统计学和临床变量。使用方差分析及事后Tukey诚实显著差异检验以及Pearson χ2检验及事后Bonferroni校正的独立比例z检验评估不同时间点的差异(显著性:P≤.05)。分别采用Kaplan-Meier、Cox回归和多变量逻辑回归分析来研究首次手术后无复发生存和30天再入院的预测因素。
最终队列中的146例患者,诊断时的平均年龄为40.3岁,52.1%为女性。初次就诊时肿瘤的平均最大直径为4.3 cm。大多数初次出现的症状在最近一次随访时显著减轻,包括头痛(初次就诊时:40.4%/最近一次随访时:8.8%,P<.001)、眩晕/恶心/呕吐(33.1%/3.7%,P<.001)、共济失调/协调障碍(22.8%/4.4%,P<.001)和癫痫发作(11.8%/2.9%,P<.005)。同样,在第II对脑神经(CN)功能缺损(11.0%/3.7%,P=.020)、第V对脑神经(11.8%/3.7%,P=.012)和第VIII对脑神经兴奋症状(11.8%/2.9%,P=.005)方面也观察到显著改善。首次切除术后,12.5%的患者在30天内再次入院;放置腰大池引流与再入院几率较高相关(调整后的优势比[95%CI]=8.26[1.29 - 88.19])。术后即刻MRI显示有肿瘤残留的证据与首次手术后复发时间较短相关(P=.023)。
颅内表皮样囊肿的临床进展以一系列令人困扰的症状和明显的复发倾向为特征,尤其是在次全切除术后。然而,即使需要再次手术,症状改善仍是常见的,且死亡率极低。